At EHA, we believe progress in hematology comes from the strength of a united community. When we come together—as researchers, clinicians, and advocates—we are more than dedicated individuals; we are a powerful force for change. By making a difference together, we can achieve a world of Borderless Hematology.
Learn more about how we work to realize Borderless Hematology: https://t.co/q7nOlJfXNI
@young_eha
Special thanks to our former department head, @YStepanishyna , for unwavering support - even from a distance we did it together. To the strong legacy built by our former team.
Finally, the Bone Marrow Department at the National Cancer Institute has achieved what we’ve worked towards for 10 years! 🎉 We are now the 4th center in Ukraine to provide allogeneic bone marrow transplantation.
It’s a shame to give a voice to #RussianPropaganda especially from russian propagandists like #AnastasiaTrofimova there are no excuses for people who brought the war and death in the peaceful #Ukraine the most awful thing that this film was sponsored by #Canada
Hugely important trial results in @JCO_ASCO
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results | Journal of Clinical Oncology https://t.co/Dz6gbXBn2h
British Journal of Haematology | Wiley Online Library https://t.co/6ypE5KH5KZ I'm proud of our young but successful lymphoma registry. I'm thankful for the teamwork with the Italian group and my current and former colleagues from the NCI, who are now spread out all over the world
Happy to see our paper about long term results of the H10 trial for early stage Hodgkin lymphoma. Fantastic collaboration for LYSA with FIL and EORTC.
https://t.co/gAD75zSFRQ
@YStepanishyna@NazarShokun@marti_manni Hope that Ukrainian Lymphoma Registry will produce a big data more and more in the future!
But today, about current reality! #ash2022 Never give up!